Le Lézard
Classified in: Health, Covid-19 virus
Subjects: PSF, AVO

Ontario's doctors offer advice on how to get through this phase of pandemic


TORONTO, Dec. 16, 2021 /CNW/ - Ontario's doctors support the decisions taken by all levels of government this week to help curb the spread of the Omicron variant of COVID-19 and appreciate the ongoing sacrifices all Canadians are making.

"We have considerable experience responding to different variants and the prior waves of the pandemic," said Dr. Adam Kassam, president of the Ontario Medical Association. "We will get through this one as well. We have the skills and expertise."

The Omicron variant is highly contagious, which makes it even more important than ever that all Ontarians get fully vaccinated and get their children vaccinated as well.

In addition, doctors urge all Ontarians to limit their contacts with other people this holiday season and avoid crowded places. Keep family gatherings small. Consider holding office or other celebrations virtually.

The OMA calls on all levels of government to expedite and expand the distribution of vaccines and rapid tests and to continue to follow the science and evidence around COVID-19 to determine whether additional public health measures are needed.

"If you have questions about COVID, ask your doctor or local public health unit," said Dr. Kassam. "Please be patient with one another and with health-care workers who are doing their best to keep our communities safe and navigate this new phase of the pandemic."

About the OMA

The Ontario Medical Association represents Ontario's 43,000-plus physicians, medical students and retired physicians, advocating for and supporting doctors while strengthening the leadership role of doctors in caring for patients. Our vision is to be the trusted voice in transforming Ontario's health-care system.

SOURCE Ontario Medical Association


These press releases may also interest you

at 05:09
Medical imaging IT and cybersecurity company Sectra (STO: SECT B) is publishing its Annual Report and Sustainability Report for the 2023/2024 fiscal year today. This report also includes the Corporate Governance Report for the same period. The...

at 03:20
Calliditas Therapeutics AB (STO: CALTX) ("Calliditas") today announces that its partner Viatris Pharmaceutical Japan G.K. ("Viatris") has initiated a phase III clinical trial in Japan with Nefecon, named VR-205 in the Japanese market, in Japanese...

at 03:00
Global biotechnology leader CSL Behring today announced that two hemophilia B patients were treated with the gene therapy HEMGENIX® (etranacogene dezaparvovec) at Hemophilia Treatment Centers in France. This milestone achievement makes HEMGENIX® the...

at 02:30
SOPHiA GENETICS , a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced that Dhiti Omics Technologies, a precision molecular diagnostics service provider in India, is live on the SOPHiA...

at 01:15
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the Phase II/III SKYSCRAPER-06 study, evaluating tiragolumab plus Tecentriq® (atezolizumab) and chemotherapy versus pembrolizumab and chemotherapy as an initial...

at 01:05
BenevolentAI ("BenevolentAI" or the "Company") (Euronext Amsterdam: BAI), a leader in applying advanced AI to accelerate biopharma drug discovery, announces the appointment of Deutsche Numis as the Company's Financial and Capital Markets Adviser,...



News published on and distributed by: